Anterix Inc.
74.90USD
+1.7400 (+2.38%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ATEX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.28▼ | -$0.24 | 0 | 0 |
| Next quarter | -$0.21▲ | -$0.23 | 0 | 0 |
| Current year | -$1.11▲ | -$1.33 | 0 | 0 |
| Next year | -$0.59▼ | $0 | 0 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.17 | $0.01 | +0.18 (+106.1%) |
| 2026-03-31 | $1.37 | $0.98 | -0.39 (-28.5%) |
| 2025-12-31 | -$0.55 | -$0.35 | +0.20 (+36.4%) |
| 2025-09-30 | -$0.6 | $2.86 | +3.46 (+576.7%) |
21 ratings from 3 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $133 $130 | Aug 13, 2026 |
| JP Morgan | Maintained | Overweight | $50 $133 | Jul 20, 2026 |
| B. Riley Securities | Downgraded from Buy | Neutral | $44 $69 | Jun 4, 2026 |
| JP Morgan | Maintained | Overweight | $67 $50 | Oct 17, 2025 |
| JP Morgan | Maintained | Overweight | $61 $67 | Feb 13, 2025 |
| JP Morgan | Maintained | Overweight | $60 $61 | Aug 8, 2024 |
| B. Riley Securities | Maintained | Buy | $75 | Feb 16, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $42 $41 | Aug 1, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $63 $42 | Feb 24, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $65 $63 | Feb 10, 2022 |
| Morgan Stanley | Maintained | Equal-Weight | $51 $65 | Aug 4, 2021 |
| Morgan Stanley | Maintained | Equal-Weight | $48 $51 | Jun 9, 2021 |
| JP Morgan | Upgraded from Neutral | Overweight | $40 $50 | Feb 17, 2021 |
| JP Morgan | Upgraded from Underweight | Neutral | $30 $40 | Feb 1, 2021 |
| Morgan Stanley | Maintained | Equal-Weight | $50 $48 | Jan 27, 2021 |
| JP Morgan | Downgraded from Neutral | Underweight | $30 | Nov 18, 2020 |
| Morgan Stanley | Maintained | Equal-Weight | $51 $50 | Jul 1, 2020 |
| B. Riley Securities | Maintained | Buy | $59 $75 | May 22, 2020 |
| Morgan Stanley | Maintained | Equal-Weight | $50 $51 | Feb 20, 2020 |
| JP Morgan | Initiated | Neutral | $58 | Feb 3, 2020 |
| Morgan Stanley | Initiated | Equal-Weight | $50 | Nov 11, 2019 |
80 filings from 17 insiders · 22 buy / 19 sell over 6m
Officers and directors of ATEX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Marquez ElenaOfficer, Chief Financial Officer | ExerciseStock Option (Right to Buy) | 1.2k | — | — | Oct 9, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Sell | 210 | $81.90 | $17k | Oct 9, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Sell | 1.0k | $80.22 | $82k | Oct 9, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Exercise | 1.2k | $40.00 | $49k | Oct 9, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Sell | 100 | $82.50 | $8k | Oct 9, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Sell | 400 | $81.80 | $33k | Oct 9, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Sell | 3.3k | $80.16 | $261k | Oct 9, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Tax | 473 | $84.33 | $40k | Oct 5, 2026 |
| Marquez ElenaOfficer, Chief Financial Officer | Tax | 1.3k | $81.75 | $108k | Sep 29, 2026 |
| Lang Scott A.Director; Officer, President and CEO | Sell | 15.0k | $80.00 | $1.20M | Sep 21, 2026 |
| Lang Scott A.Director; Officer, President and CEO | Sell | 15.0k | $80.00 | $1.20M | Sep 21, 2026 |
| DANIELS LESLIE BDirector | Sell | 2.5k | $83.83 | $210k | Sep 10, 2026 |
| Martin HeatherOfficer, Chief Marketing Officer; Chief of Staff | Sell | 8.1k | $84.20 | $679k | Sep 10, 2026 |
| Martin HeatherOfficer, Chief Marketing Officer; Chief of Staff | Tax | 3.5k | $85.44 | $296k | Sep 9, 2026 |
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Sell | 293 | $85.44 | $25k | Sep 8, 2026 |
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Sell | 4.1k | $85.44 | $347k | Sep 8, 2026 |
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Sell | 293 | $85.44 | $25k | Sep 8, 2026 |
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Exercise | 6.8k | $34.96 | $239k | Sep 8, 2026 |
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Tax | 2.8k | $86.27 | $239k | Sep 8, 2026 |
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Sell | 4.1k | $85.44 | $347k | Sep 8, 2026 |
No analyst notes on ATEX yet.
Analyst Ratings
3 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 1 | 1 | 0 | 0 | Buy2.00 |
| 1 mo ago | 1 | 1 | 1 | 0 | 0 | Buy2.00 |
| 2 mo ago | 1 | 1 | 1 | 0 | 0 | Buy2.00 |
Members whose judged calls on ATEX have played out most reliably.
No settled calls on ATEX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice